| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 10 | 2022 | 133 | 4.010 |
Why?
|
| Pseudomonas Infections | 9 | 2022 | 83 | 3.050 |
Why?
|
| Cytokines | 7 | 2016 | 866 | 1.510 |
Why?
|
| Alveolar Bone Loss | 8 | 2015 | 40 | 1.470 |
Why?
|
| Osteoclasts | 8 | 2016 | 132 | 1.410 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 9 | 2016 | 18 | 1.320 |
Why?
|
| Alginates | 4 | 2020 | 35 | 1.200 |
Why?
|
| Dual Specificity Phosphatase 1 | 5 | 2014 | 22 | 1.160 |
Why?
|
| Osteogenesis | 2 | 2016 | 152 | 0.980 |
Why?
|
| Cystic Fibrosis | 6 | 2022 | 283 | 0.840 |
Why?
|
| Mice | 28 | 2020 | 8472 | 0.750 |
Why?
|
| Genetic Engineering | 2 | 2020 | 41 | 0.740 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 49 | 0.720 |
Why?
|
| Tobramycin | 1 | 2019 | 38 | 0.700 |
Why?
|
| Gene Deletion | 2 | 2020 | 235 | 0.690 |
Why?
|
| Pneumonia | 1 | 2019 | 110 | 0.650 |
Why?
|
| Mutation | 8 | 2022 | 1213 | 0.620 |
Why?
|
| Animals | 37 | 2020 | 20877 | 0.620 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 3 | 2004 | 6 | 0.620 |
Why?
|
| Inflammation Mediators | 4 | 2015 | 244 | 0.610 |
Why?
|
| Pasteurellaceae Infections | 1 | 2016 | 2 | 0.580 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2016 | 63 | 0.550 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2015 | 24 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 2790 | 0.530 |
Why?
|
| RNA, Messenger | 8 | 2015 | 1663 | 0.520 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2005 | 12 | 0.510 |
Why?
|
| Biofilms | 3 | 2019 | 72 | 0.500 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 1026 | 0.500 |
Why?
|
| Sigma Factor | 1 | 2013 | 5 | 0.470 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2013 | 16 | 0.470 |
Why?
|
| Lung | 4 | 2019 | 849 | 0.460 |
Why?
|
| Pasteurellaceae | 1 | 2012 | 1 | 0.450 |
Why?
|
| Fenretinide | 1 | 2012 | 26 | 0.440 |
Why?
|
| Lipoproteins | 5 | 2005 | 161 | 0.430 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2011 | 6 | 0.410 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 92 | 0.400 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 2550 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 239 | 0.380 |
Why?
|
| Periodontitis | 4 | 2015 | 47 | 0.370 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 231 | 0.370 |
Why?
|
| Models, Animal | 3 | 2008 | 252 | 0.370 |
Why?
|
| Sitosterols | 4 | 2005 | 8 | 0.360 |
Why?
|
| Cell Line | 11 | 2013 | 1752 | 0.360 |
Why?
|
| Lipopolysaccharides | 6 | 2014 | 455 | 0.360 |
Why?
|
| Dependovirus | 2 | 2010 | 34 | 0.350 |
Why?
|
| Adenoviridae | 7 | 2006 | 295 | 0.340 |
Why?
|
| Ceramides | 1 | 2012 | 578 | 0.330 |
Why?
|
| Interleukin-6 | 5 | 2016 | 330 | 0.320 |
Why?
|
| Genetic Therapy | 6 | 2010 | 291 | 0.320 |
Why?
|
| Phospholipids | 1 | 2008 | 108 | 0.320 |
Why?
|
| Surface-Active Agents | 1 | 2008 | 57 | 0.310 |
Why?
|
| Interleukin-1beta | 3 | 2016 | 88 | 0.300 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2009 | 183 | 0.300 |
Why?
|
| Hexuronic Acids | 2 | 2019 | 24 | 0.290 |
Why?
|
| Glucuronic Acid | 2 | 2019 | 25 | 0.290 |
Why?
|
| Mice, Knockout | 8 | 2014 | 1692 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 626 | 0.290 |
Why?
|
| Lung Diseases | 1 | 2008 | 175 | 0.290 |
Why?
|
| Genetic Variation | 3 | 2012 | 220 | 0.290 |
Why?
|
| Transgenes | 2 | 2005 | 92 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 5 | 2007 | 614 | 0.280 |
Why?
|
| Inflammation | 6 | 2015 | 1030 | 0.280 |
Why?
|
| Macrophages | 6 | 2015 | 647 | 0.270 |
Why?
|
| X-Ray Microtomography | 6 | 2015 | 50 | 0.270 |
Why?
|
| Intermediate Filament Proteins | 1 | 2005 | 12 | 0.270 |
Why?
|
| Rats, Inbred SHR | 2 | 2005 | 95 | 0.250 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 1293 | 0.240 |
Why?
|
| Genetic Vectors | 7 | 2010 | 311 | 0.240 |
Why?
|
| Simvastatin | 2 | 2013 | 34 | 0.240 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 209 | 0.240 |
Why?
|
| Rats, Inbred WKY | 1 | 2003 | 48 | 0.230 |
Why?
|
| Rats | 10 | 2013 | 5300 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 290 | 0.230 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 188 | 0.220 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 222 | 0.220 |
Why?
|
| Gestational Age | 1 | 2004 | 389 | 0.220 |
Why?
|
| Metabolic Syndrome | 2 | 2014 | 191 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 331 | 0.210 |
Why?
|
| Viral Envelope Proteins | 3 | 2006 | 43 | 0.210 |
Why?
|
| Humans | 27 | 2022 | 68525 | 0.210 |
Why?
|
| Phosphorylation | 3 | 2015 | 1199 | 0.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 212 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 434 | 0.200 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 91 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2022 | 163 | 0.190 |
Why?
|
| Blotting, Western | 2 | 2013 | 954 | 0.180 |
Why?
|
| Phenotype | 2 | 2020 | 946 | 0.180 |
Why?
|
| Virulence | 1 | 2020 | 51 | 0.180 |
Why?
|
| Culture Media | 1 | 2020 | 155 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2000 | 117 | 0.180 |
Why?
|
| Amikacin | 1 | 2019 | 13 | 0.180 |
Why?
|
| Apoptosis | 5 | 2013 | 1640 | 0.180 |
Why?
|
| Cholesterol | 4 | 2013 | 331 | 0.180 |
Why?
|
| Nitrites | 1 | 2019 | 53 | 0.170 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 120 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 4 | 2014 | 247 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 15 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2005 | 120 | 0.170 |
Why?
|
| Sputum | 1 | 2019 | 51 | 0.170 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 226 | 0.170 |
Why?
|
| Pyrimidines | 1 | 2020 | 178 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2005 | 112 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 196 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2019 | 176 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 244 | 0.150 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2016 | 1 | 0.140 |
Why?
|
| Ebola Vaccines | 2 | 2006 | 2 | 0.140 |
Why?
|
| Gene Silencing | 3 | 2015 | 137 | 0.140 |
Why?
|
| Marburg Virus Disease | 2 | 2006 | 2 | 0.140 |
Why?
|
| Marburgvirus | 2 | 2006 | 2 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 216 | 0.140 |
Why?
|
| Phytosterols | 3 | 2005 | 8 | 0.140 |
Why?
|
| Gene Targeting | 2 | 2007 | 58 | 0.140 |
Why?
|
| Bone Resorption | 2 | 2014 | 64 | 0.140 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2015 | 8 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 134 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2012 | 2688 | 0.130 |
Why?
|
| Autoantigens | 1 | 2015 | 91 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2013 | 234 | 0.130 |
Why?
|
| Chemokine CXCL2 | 1 | 2014 | 13 | 0.130 |
Why?
|
| Sterols | 2 | 2005 | 13 | 0.130 |
Why?
|
| Chemokine CXCL1 | 1 | 2014 | 21 | 0.130 |
Why?
|
| Male | 13 | 2019 | 37281 | 0.130 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 217 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 175 | 0.120 |
Why?
|
| Stomatitis | 1 | 2013 | 8 | 0.120 |
Why?
|
| ELAV Proteins | 1 | 2013 | 17 | 0.120 |
Why?
|
| Prostatic Neoplasms | 3 | 2007 | 778 | 0.120 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2013 | 22 | 0.120 |
Why?
|
| Gamma Rays | 1 | 2013 | 64 | 0.120 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 76 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2012 | 432 | 0.120 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 20 | 0.120 |
Why?
|
| Tetracycline | 2 | 2005 | 29 | 0.120 |
Why?
|
| Mucus | 1 | 2013 | 33 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2012 | 156 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 272 | 0.110 |
Why?
|
| Mouth Neoplasms | 1 | 2015 | 206 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2013 | 233 | 0.110 |
Why?
|
| Periodontal Diseases | 1 | 2013 | 54 | 0.110 |
Why?
|
| Interleukin-10 | 2 | 2012 | 144 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2673 | 0.110 |
Why?
|
| Gram-Positive Bacteria | 1 | 2012 | 23 | 0.110 |
Why?
|
| Biodiversity | 1 | 2012 | 16 | 0.110 |
Why?
|
| Gastrointestinal Contents | 1 | 2012 | 13 | 0.110 |
Why?
|
| Periapical Periodontitis | 1 | 2012 | 1 | 0.110 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 16 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 507 | 0.110 |
Why?
|
| Female | 11 | 2019 | 38015 | 0.110 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 370 | 0.100 |
Why?
|
| COS Cells | 1 | 2012 | 155 | 0.100 |
Why?
|
| Protein Kinase C | 1 | 2012 | 270 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 250 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2015 | 617 | 0.100 |
Why?
|
| Periodontal Ligament | 1 | 2010 | 16 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2013 | 2083 | 0.100 |
Why?
|
| Protein Transport | 1 | 2011 | 280 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 492 | 0.090 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2000 | 44 | 0.090 |
Why?
|
| Pneumonia, Bacterial | 1 | 2010 | 19 | 0.090 |
Why?
|
| Osteonectin | 1 | 2010 | 69 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2012 | 295 | 0.090 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 173 | 0.090 |
Why?
|
| RANK Ligand | 3 | 2014 | 73 | 0.090 |
Why?
|
| Antigens, Viral | 2 | 2006 | 35 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 624 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2009 | 71 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 561 | 0.080 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 51 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2008 | 149 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1446 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 117 | 0.080 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2008 | 61 | 0.080 |
Why?
|
| RNA Interference | 1 | 2009 | 266 | 0.080 |
Why?
|
| Androgen-Binding Protein | 1 | 2007 | 1 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2008 | 411 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 1032 | 0.070 |
Why?
|
| Viral Fusion Proteins | 1 | 2006 | 4 | 0.070 |
Why?
|
| Species Specificity | 2 | 2006 | 302 | 0.070 |
Why?
|
| Exons | 3 | 2002 | 122 | 0.070 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2006 | 12 | 0.070 |
Why?
|
| Viral Vaccines | 1 | 2005 | 17 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2005 | 237 | 0.070 |
Why?
|
| Mice, Inbred Strains | 3 | 2014 | 181 | 0.070 |
Why?
|
| Weight Loss | 1 | 2008 | 319 | 0.070 |
Why?
|
| Sphingolipids | 1 | 2009 | 337 | 0.070 |
Why?
|
| Nestin | 1 | 2005 | 6 | 0.070 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 57 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2005 | 59 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2005 | 31 | 0.070 |
Why?
|
| Age Factors | 2 | 2012 | 1860 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2005 | 189 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 127 | 0.060 |
Why?
|
| Liver | 3 | 2005 | 1118 | 0.060 |
Why?
|
| Vaccination | 1 | 2006 | 182 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2012 | 1034 | 0.060 |
Why?
|
| Prostate | 2 | 2004 | 116 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1174 | 0.060 |
Why?
|
| Base Sequence | 3 | 2002 | 1015 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 307 | 0.060 |
Why?
|
| Palmitic Acid | 2 | 2014 | 51 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2005 | 396 | 0.060 |
Why?
|
| Genotype | 2 | 2010 | 785 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2004 | 38 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2005 | 244 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 62 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 1082 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 1849 | 0.060 |
Why?
|
| Fetal Growth Retardation | 1 | 2004 | 56 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 176 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2001 | 159 | 0.060 |
Why?
|
| Pedigree | 2 | 2001 | 159 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 144 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 541 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2007 | 753 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2002 | 301 | 0.050 |
Why?
|
| Glioma | 1 | 2003 | 140 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2014 | 241 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2003 | 371 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 1 | 2022 | 70 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 328 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2002 | 251 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2002 | 93 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 431 | 0.050 |
Why?
|
| Cell Count | 2 | 2012 | 248 | 0.050 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2001 | 6 | 0.050 |
Why?
|
| Antibodies, Viral | 3 | 2006 | 110 | 0.050 |
Why?
|
| Cholesterol, Dietary | 1 | 2001 | 22 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2022 | 98 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2012 | 2453 | 0.050 |
Why?
|
| Infant | 2 | 2012 | 2891 | 0.050 |
Why?
|
| Neutrophils | 2 | 2012 | 204 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 945 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 1999 | 37 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2012 | 3185 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 371 | 0.040 |
Why?
|
| Plankton | 1 | 2019 | 3 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2000 | 161 | 0.040 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1999 | 44 | 0.040 |
Why?
|
| Fas Ligand Protein | 3 | 2005 | 64 | 0.040 |
Why?
|
| Alleles | 1 | 2000 | 386 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2005 | 200 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 231 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 689 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 618 | 0.040 |
Why?
|
| DNA | 1 | 2000 | 597 | 0.040 |
Why?
|
| Phylogeny | 2 | 2012 | 196 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1999 | 285 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 756 | 0.040 |
Why?
|
| Child | 2 | 2012 | 6400 | 0.030 |
Why?
|
| Adult | 3 | 2012 | 21375 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 132 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 23 | 0.030 |
Why?
|
| Arginine | 1 | 2015 | 102 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 26 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 294 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 81 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 101 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1329 | 0.030 |
Why?
|
| Brain | 1 | 2005 | 2175 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2013 | 10 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 48 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 8903 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 119 | 0.030 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2013 | 22 | 0.030 |
Why?
|
| Maxillary Diseases | 1 | 2013 | 13 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2013 | 36 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2013 | 48 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 175 | 0.030 |
Why?
|
| Gingivitis | 1 | 2013 | 16 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2014 | 98 | 0.030 |
Why?
|
| Gingiva | 1 | 2013 | 34 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 111 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 51 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2006 | 165 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 101 | 0.030 |
Why?
|
| Leukocytes | 1 | 2013 | 99 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2013 | 68 | 0.030 |
Why?
|
| Neoplasms | 1 | 2005 | 1660 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 56 | 0.030 |
Why?
|
| Triglycerides | 1 | 2013 | 184 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 447 | 0.030 |
Why?
|
| Stem Cells | 1 | 2014 | 248 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 160 | 0.030 |
Why?
|
| Dental Pulp Exposure | 1 | 2012 | 1 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 85 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 261 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 32 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2012 | 24 | 0.030 |
Why?
|
| Molar | 1 | 2012 | 27 | 0.030 |
Why?
|
| Feces | 1 | 2012 | 88 | 0.030 |
Why?
|
| Mandibular Diseases | 1 | 2012 | 28 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 62 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2013 | 308 | 0.030 |
Why?
|
| Skull | 1 | 2012 | 63 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 2012 | 124 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 43 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 230 | 0.030 |
Why?
|
| Chickens | 1 | 2012 | 232 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 189 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2012 | 99 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 261 | 0.020 |
Why?
|
| Gingival Diseases | 1 | 2010 | 22 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 357 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2010 | 61 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 791 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 617 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 631 | 0.020 |
Why?
|
| Maxilla | 1 | 2010 | 63 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2010 | 175 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 144 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 99 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 4655 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 331 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 1074 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 902 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 21 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2007 | 35 | 0.020 |
Why?
|
| Feedback | 1 | 2007 | 90 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 31 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2006 | 19 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 89 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2006 | 124 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 87 | 0.020 |
Why?
|
| Ebolavirus | 1 | 2006 | 2 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2005 | 22 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2005 | 57 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 80 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2005 | 18 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2005 | 7 | 0.020 |
Why?
|
| Immunization | 1 | 2006 | 86 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2006 | 237 | 0.020 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2005 | 2 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 79 | 0.020 |
Why?
|
| Spleen | 1 | 2005 | 301 | 0.020 |
Why?
|
| Response Elements | 1 | 2004 | 29 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 532 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2004 | 71 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 38 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2004 | 19 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 742 | 0.020 |
Why?
|
| Bile | 1 | 2004 | 35 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2003 | 18 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 32 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2003 | 40 | 0.010 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2003 | 19 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2003 | 30 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 81 | 0.010 |
Why?
|
| Intestines | 1 | 2004 | 114 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 100 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2003 | 65 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 376 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 194 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 246 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 782 | 0.010 |
Why?
|
| Chromosomes | 1 | 2002 | 17 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 68 | 0.010 |
Why?
|
| Glutamine | 1 | 2002 | 45 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 282 | 0.010 |
Why?
|
| Doxycycline | 1 | 2001 | 49 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 167 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 770 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5708 | 0.010 |
Why?
|
| Absorption | 1 | 2001 | 49 | 0.010 |
Why?
|
| Japan | 1 | 2001 | 68 | 0.010 |
Why?
|
| North America | 1 | 2001 | 111 | 0.010 |
Why?
|
| Europe | 1 | 2001 | 195 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 597 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 852 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1447 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 901 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 21119 | 0.010 |
Why?
|